Clinical Trials Browser

Phase 2 × toripalimab × Lymphoid × Clear all

NCT04338282 2020-04-08

Maintenance Therapy With Anti-PD-1 Antibody for Patients With NK/T-cell Lymphoma

Phase 2 Unknown

Lymphoma, Extranodal NK-T-Cell